Alcohol use disorders are responsible for 5.9% of all death annually and 5.1% of the global
disease burden. It has been suggested that alcohol abuse can modify gene expression …

Substance use disorders, including alcohol use disorder, are a public health concern that
affect more than 150 million people globally. The opioid antagonist naltrexone is being …

Abstract Purpose of Review The tissue damage and trauma associated with surgery almost
always result in acute postoperative pain. The intensity of postoperative pain can range from …

Steatotic liver disease (SLD), including metabolic dysfunction-associated steatotic liver
disease (MASLD) and alcohol-associated liver disease (ALD), is the primary cause of illness …

Background: Alcohol use disorder (AUD) is common and deadly. Naltrexone is a treatment
for AUD. Previous research examined factors that predict Ohio Advanced Practice …

This issue of the Journal brings together very clinically relevant papers that present new
data aimed at improving interventions for the treatment of alcohol use disorder, bingeeating …

Chronic pain and alcohol use disorder (AUD) are highly comorbid, but whether the two
conditions share common brain pathways is unclear. Prior work shows that the anterior …

Healthcare providers harbor more bias toward individuals with substance use disorders
(SUDs) compared to most medical conditions. This stigma worsens the quality of these …

Naltrexone (NTX), a homologue of the opiate antidote naloxone, is an orally active long-
acting mu-opioid receptor (MOP) antagonist used in the treatment of opiate dependence …